Cytoreductive prostatectomy in metastatic prostate cancer: a systematic review
Author:
Affiliation:
1. Copenhagen Prostate Cancer Center, Department of Urology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
Publisher
Informa UK Limited
Subject
Urology,Nephrology
Link
https://www.tandfonline.com/doi/pdf/10.1080/21681805.2017.1363816
Reference46 articles.
1. EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate Cancer
2. Androgen Deprivation Therapy (ADT) Plus Docetaxel Versus ADT Alone in Metastatic Non castrate Prostate Cancer: Impact of Metastatic Burden and Long-term Survival Analysis of the Randomized Phase 3 GETUG-AFU15 Trial
3. Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial
4. Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
5. The predictive value of ERG protein expression for development of castration-resistant prostate cancer in hormone-naïve advanced prostate cancer treated with primary androgen deprivation therapy
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Cyclic elastoplasticity and XFEM based fatigue life assessment of out-of-plane gusset welded joints;International Journal of Fatigue;2024-01
2. Cytoreductive radical prostatectomy versus no local treatment in patients with metastatic prostate cancer;Medwave;2023-05-25
3. Experimental and Numerical Investigation of Double Pass Overlapping Beads by Twin-Wire Welding Additive Manufacturing Process;Transactions of the Indian Institute of Metals;2022-11-11
4. A systematic review of cytoreductive prostatectomy outcomes and complications in oligometastatic disease;Asian Journal of Urology;2022-11
5. Total pelvic exenteration surgery for loco‐regionally advanced prostate cancer, is it justifiable?;BJU International;2022-10-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3